As of May 2024 Xenon Pharmaceuticals has a market cap of $3.06 Billion. This makes Xenon Pharmaceuticals the world's 3461th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $3.06 B | -11.67% |
2023 | $3.46 B | 40.59% |
2022 | $2.46 B | 53.02% |
2021 | $1.61 B | 199.29% |
2020 | $0.53 B | 45.97% |
2019 | $0.36 B | 127.04% |
2018 | $0.16 B | 219.57% |
2017 | $50.84 M | -63.1% |
2016 | $0.13 B | 19.13% |
2015 | $0.11 B | -58.71% |
2014 | $0.28 B |
On May 14th, 2024 the market cap of Xenon Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Coherus BioSciences
CHRS | $0.23 B | -92.21% | ๐บ๐ธ USA |
Atara Biotherapeutics ATRA | $72.85 M | -97.62% | ๐บ๐ธ USA |